The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK ...

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

In a groundbreaking study, scientists from China have successfully created mice with two biological fathers. Though the ...

The X contains more genes related to brain function than does any other chromosome. “The X chromosome may be a treasure trove of genes that influence cognition, and these could be therapeutic targets, ...

CRISPR Therapeutics AG (CRSP) closed at $41.21 in the latest trading session, marking a -1.44% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.47%. Meanwhile ...

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

Once a week, Sun Kai has a video call with his mother, and they discuss his day-to-day life. But Sun’s mother died five years ...

Results prove that inversions can be generated in plants without causing further unwanted changes in the expression of genetic information.

Leerink Partnrs boosted their FY2024 earnings per share (EPS) estimates for CRISPR Therapeutics in a note issued to investors ...

RFK Jr.'s comments about the gene-editing technology raise a question about how he would regulate it as head of HHS.

Researchers use CRISPR to overcome seemingly insurmontable reproductive barriers — but that doesn't mean this could work for humans.

Morgan Stanley lowered the firm’s price target on Crispr Therapeutics (CRSP) to $30 from $45 and keeps an Underweight rating on the shares. The ...